scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41391-019-0156-Z |
P698 | PubMed publication ID | 31147628 |
P50 | author | Shahrokh Shariat | Q7462263 |
M Kardoust Parizi | Q85887779 | ||
Markus Hartenbach | Q88687449 | ||
Shoji Kimura | Q89482497 | ||
Florian Janisch | Q89499908 | ||
Takehiro Iwata | Q91806148 | ||
Shin Egawa | Q92694544 | ||
Beat Foerster | Q39051546 | ||
Mohammad Abufaraj | Q39051577 | ||
Nicola Fossati | Q41202163 | ||
P2093 | author name string | Alberto Briganti | |
P2860 | cites work | Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. | Q48370281 |
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT. | Q52984262 | ||
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. | Q52985406 | ||
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography. | Q52991043 | ||
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial pr | Q88565499 | ||
Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes | Q89222149 | ||
Ga-labeled Prostate-specific Membrane Antigen Ligand-positron-emission Tomography: Still Just the Tip of the Iceberg | Q89379875 | ||
Accuracy of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage Lymphadenectomy | Q90517559 | ||
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology | Q91177742 | ||
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and | Q91655726 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews | Q29619492 | ||
Predicting 15-year prostate cancer specific mortality after radical prostatectomy | Q33759725 | ||
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | Q35043569 | ||
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis | Q36065223 | ||
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature | Q37978983 | ||
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy | Q38853977 | ||
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis. | Q38934646 | ||
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | Q38939206 | ||
Role of salvage lymph node dissection in prostate cancer | Q38943636 | ||
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer | Q38945683 | ||
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer | Q39009150 | ||
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy | Q39724803 | ||
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma | Q40327142 | ||
Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up. | Q40468376 | ||
Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival | Q40955829 | ||
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer | Q42257970 | ||
Bivariate random effects meta-analysis of ROC curves. | Q45923370 | ||
Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients | Q47115390 | ||
P433 | issue | 1 | |
P304 | page(s) | 1-10 | |
P577 | publication date | 2019-05-30 | |
P1433 | published in | Prostate Cancer and Prostatic Diseases | Q2108326 |
P1476 | title | Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis | |
P478 | volume | 23 |
Q99583250 | The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer | cites work | P2860 |
Search more.